A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19 and is mostly person-to-person transmitted through respiratory droplets. The implications of the strategies implemented to prevent COVID-19 transmission on other infectious diseases are unclear. We aimed to appraise trends...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/6/3070 |
id |
doaj-5b25606fa99f40139957b19be7d1154c |
---|---|
record_format |
Article |
spelling |
doaj-5b25606fa99f40139957b19be7d1154c2021-03-17T00:05:50ZengMDPI AGInternational Journal of Environmental Research and Public Health1661-78271660-46012021-03-01183070307010.3390/ijerph18063070A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 PandemicRavit Bassal0Lital Keinan-Boker1Dani Cohen2Israel Center for Disease Control, Ministry of Health, Sheba Medical Center, Ramat Gan 5262160, IsraelIsrael Center for Disease Control, Ministry of Health, Sheba Medical Center, Ramat Gan 5262160, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, IsraelSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19 and is mostly person-to-person transmitted through respiratory droplets. The implications of the strategies implemented to prevent COVID-19 transmission on other infectious diseases are unclear. We aimed to appraise trends in the incidence of salmonellosis, shigellosis and campylobacteriosis in Israel during COVID-19 pandemic. Positive stool samples for <i>Salmonella</i>, <i>Shigella</i> and <i>Campylobacter</i> are reported on a monthly basis to the Israel Center for Disease Control from sentinel laboratories, within the framework of a surveillance network of bacterial culture-proven enteric diseases. Age-adjusted incidence rates per 100,000 of shigellosis, salmonellosis and campylobacteriosis were calculated. Mean rates before and after the local onset of COVID-19 pandemic in Israel were compared and Relative Risk Reduction (RRR) was calculated. Joinpoint was used to evaluate secular trends. The mean age-adjusted incidence rate of shigellosis in March–July 2020 was lower than the rate observed in March–July 2018–2019 (RRR = 86.6%), but also decreased for salmonellosis (RRR = 33.0%) and campylobacteriosis (RRR = 30.0%). Using Joinpoint we have shown that the decrease observed for shigellosis was significantly sharper (Annual Percent Change (APC) = −77.7) between February 2020 and May 2020 than for salmonellosis (APC = −14.0) between July 2019 and April 2020 and for campylobacteriosis (APC = −1.1) between January 2018 and July 2020. The preventive measures applied to reduce transmission of COVID-19, including social distancing and hand washing, were ecologically associated with a decreased risk of bacterial enteric diseases in Israel. The association was strongest for shigellosis, a disease that is mostly person-to-person transmitted, as compared to salmonellosis and campylobacteriosis which are mostly foodborne transmitted.https://www.mdpi.com/1660-4601/18/6/3070COVID-19outbreaktrendenteric diseasesincidence |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ravit Bassal Lital Keinan-Boker Dani Cohen |
spellingShingle |
Ravit Bassal Lital Keinan-Boker Dani Cohen A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic International Journal of Environmental Research and Public Health COVID-19 outbreak trend enteric diseases incidence |
author_facet |
Ravit Bassal Lital Keinan-Boker Dani Cohen |
author_sort |
Ravit Bassal |
title |
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic |
title_short |
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic |
title_full |
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic |
title_fullStr |
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic |
title_full_unstemmed |
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic |
title_sort |
significant decrease in the incidence of shigellosis in israel during covid-19 pandemic |
publisher |
MDPI AG |
series |
International Journal of Environmental Research and Public Health |
issn |
1661-7827 1660-4601 |
publishDate |
2021-03-01 |
description |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19 and is mostly person-to-person transmitted through respiratory droplets. The implications of the strategies implemented to prevent COVID-19 transmission on other infectious diseases are unclear. We aimed to appraise trends in the incidence of salmonellosis, shigellosis and campylobacteriosis in Israel during COVID-19 pandemic. Positive stool samples for <i>Salmonella</i>, <i>Shigella</i> and <i>Campylobacter</i> are reported on a monthly basis to the Israel Center for Disease Control from sentinel laboratories, within the framework of a surveillance network of bacterial culture-proven enteric diseases. Age-adjusted incidence rates per 100,000 of shigellosis, salmonellosis and campylobacteriosis were calculated. Mean rates before and after the local onset of COVID-19 pandemic in Israel were compared and Relative Risk Reduction (RRR) was calculated. Joinpoint was used to evaluate secular trends. The mean age-adjusted incidence rate of shigellosis in March–July 2020 was lower than the rate observed in March–July 2018–2019 (RRR = 86.6%), but also decreased for salmonellosis (RRR = 33.0%) and campylobacteriosis (RRR = 30.0%). Using Joinpoint we have shown that the decrease observed for shigellosis was significantly sharper (Annual Percent Change (APC) = −77.7) between February 2020 and May 2020 than for salmonellosis (APC = −14.0) between July 2019 and April 2020 and for campylobacteriosis (APC = −1.1) between January 2018 and July 2020. The preventive measures applied to reduce transmission of COVID-19, including social distancing and hand washing, were ecologically associated with a decreased risk of bacterial enteric diseases in Israel. The association was strongest for shigellosis, a disease that is mostly person-to-person transmitted, as compared to salmonellosis and campylobacteriosis which are mostly foodborne transmitted. |
topic |
COVID-19 outbreak trend enteric diseases incidence |
url |
https://www.mdpi.com/1660-4601/18/6/3070 |
work_keys_str_mv |
AT ravitbassal asignificantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic AT litalkeinanboker asignificantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic AT danicohen asignificantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic AT ravitbassal significantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic AT litalkeinanboker significantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic AT danicohen significantdecreaseintheincidenceofshigellosisinisraelduringcovid19pandemic |
_version_ |
1724218991583428608 |